Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9045444 Apoptosis promoters

Patent 9045444 was granted and assigned to AbbVie Inc. on June, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11993610 BCL-2 inhibitors
0
Edits on 22 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11903950 BCL-2 inhibitors
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+315 characters)
Article

Patent abstract

Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression one or more than one of an anti-apoptotic protein family member.

Edits on 21 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Jun, 2023
Edits on 22 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0904544400
Edits on 19 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09045444 Apoptosis promoters US Patent 9045444 Apoptosis promoters

Infobox
Patent Number
0904544400
Patent Number
904544400
Edits on 28 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
AbbVie Inc.
AbbVie Inc.
0
Current Assignee
AbbVie Inc.
AbbVie Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
090454440
Date of Patent
June 2, 2015
0
Patent Application Number
141956660
Date Filed
March 3, 2014
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090454440
Patent Primary Examiner
‌
Zinna Northington Davis
0
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
AbbVie Inc.
AbbVie Inc.
0
Current Assignee
AbbVie Inc.
AbbVie Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
090454440
Date of Patent
June 2, 2015
0
Patent Application Number
141956660
Date Filed
March 3, 2014
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090454440
Patent Primary Examiner
‌
Zinna Northington Davis
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09045444
Edits on 2 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 2 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09045444 Apoptosis promoters

Infobox
Is a
Patent
Patent
Patent applicant
AbbVie Inc.
AbbVie Inc.
Current assignee
AbbVie Inc.
AbbVie Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09045444
Date of patent
June 2, 2015
Patent application number
14195666
Date Filed
March 3, 2014
Patent primary examiner
‌
Zinna Northington Davis

Find more entities like US Patent 9045444 Apoptosis promoters

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.